Skip to main content
Premium Trial:

Request an Annual Quote

ABI Opens Application Support Center in Foster City

NEW YORK (GenomeWeb News) — Applied Biosystems has opened an application support center at its research and development headquarters in Foster City, Calif., the company said today.
The 10,000-square-foot facility will showcase the company’s instrumentation and software and will offer training courses and applications support for its life-science customers.
The center houses ABI technologies for DNA sequencing, fragment analysis, human identification, and real-time PCR applications, including ABI’s SOLiD high-throughput DNA sequencing system. It includes a fully staffed laboratory as well as classrooms.
The company said it offers training and application support through 20 centers around the world.
"We envision this center as providing an environment for collaborating with our customers, developing new applications, and providing comprehensive training on our technologies, all in an effort to address their most difficult research challenges and ultimately to advance their science," Mark Stevenson, president for ABI’s molecular and cell biology division, said in a statement.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.